Literature DB >> 32437647

Correction to Lancet Respir Med 2020; 8: e21.

.   

Abstract

Entities:  

Year:  2020        PMID: 32437647      PMCID: PMC7234787          DOI: 10.1016/S2213-2600(20)30235-6

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


× No keyword cloud information.
Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 2020; 8: e21—In this Correspondence, reference 4 has been removed from the end of the sentence “The expression of ACE2 is substantially increased in patients with type 1 or type 2 diabetes, who are treated with ACE inhibitors and angiotensin II type-I receptor blockers (ARBs).” This correction has been made to the online version as of May 18, 2020.
  1 in total

1.  Explosive drug information in the time of COVID-19.

Authors:  Martin Schulz; Pia M Schumacher; Juliana Schneider; André Said; Ulrich Laufs
Journal:  Can Pharm J (Ott)       Date:  2021-06-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.